Effect of oleic acid/ethanol and oleic acid/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis

International Journal of Pharmaceutics

Volumn 165, Issue 1, 1998, Pages 45-55

  Gao, S ^a   Singh, J ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

5 Fluorouracil; Oleic acid; Percutaneous absorption; Tamoxifen; Transepidermal water loss

Indexed keywords

ALCOHOL; FLUOROURACIL; OLEIC ACID; PROPYLENE GLYCOL; TAMOXIFEN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TRANSPORT; EPIDERMIS; HYDROPHILICITY; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; SKIN WATER LOSS; STRATUM CORNEUM; SWINE;

EID: 0032550357     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00430-4     Document Type: Article

References (51)

1. Abrams K., Harvell J.D., Shriner D., Wertz P., Maibach H., Maibach H.I., Rehfeld S.J. Effect of organic solvents on in vitro human skin water barrier function. J. Invest. Dermatol. 101:1993;609-613.
2. Aungst B.J., Rogers N.J., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactant, sulfoxides and amides. Int. J. Pharm. 33:1986;225-234.
3. Barry B.W. Lipid-protein-partitioning theory of skin penetration enhancement. J. Control. Release. 15:1991;237-248.
4. Barry B.W., Bennett S.L. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone throught human skin. J. Pharm. Pharmacol. 39:1987;535-546.
5. Bhatia K.S., Gao S., Singh J. Effect of penetration enhancers and iontophoresis on the FT-IR spectroscopy and LHRH permeability through porcine skin. J. Control. Release. 47:1997;81-89.
6. Bhatia K.S., Gao S., Freeman T.P., Singh J. Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. J. Pharm. Sci. 89:1997;1011-1015.
7. Bennett S.L., Barry B.W., Woodford R. Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control. J. Pharm. Pharmacol. 37:1985;298-304.
8. Boehler B.A., De Gier J., Van Deenen L.L.M. The effect of gramicidin A on the temperature dependence of water permeation through liposomal membranes prepared from phosphatidylcholines with different chains lengths. Biochim. Biophys. Acta. 512:1978;480-488.
9. Bond J.R., Barry B.W. Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin. J. Invest. Dermatol. 90:1988;810-813.
10. Catz P., Friend D.R. Alkyl esters as skin permeation enhancers for indomethacin. Int. J. Pharm. 55:1989;17-23.
11. Cotreau-Bibbo M.M., Von Moltke L.L., Greenblatt D.J. Influence of polyethylene glycol and acetone on the in vitro biotransformation of tamoxifen and alprazolam by human liver microsomes. J. Pharm. Sci. 85:1996;1180-1185.
12. Distante, F., Berardesca, E., 1995. Tansepidermal water loss. In: Berardesca, E., Elsner, P., Wilhelm, K.P., Maibach, H.I. (Eds.), Bioengineering of the skin: Methods and Instrumentation. CRC Press, Boca Raton, pp. 1-4.
13. Elias P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80:1983;44s-49s.
14. Flynn G.L. Structural approach to partitioning: Estimation of steroid partition coefficients based upon molecular constitution. J. Pharm. Sci. 60:1971;345-353.
15. Flynn, G.L., 1989. Mechanism of percutaneous absorption from physicochemical evidence. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption. Marcel Dekker, New York, pp. 27-51.
16. Flynn G.L., Stewart B. Percutaneous drug penetration: Choosing candidates for transdermal development. Drug Dev. Res. 13:1988;169-185.
17. Gao S., Singh J. Mechanism of transdermal transport of 5-fluorouracil by terpenes: carvone, 1,8-cineole and thymol. Int. J. Pharm. 154:1997;67-77.
18. Golden G.M., Guzek D.B., Kennedy A.H., McKie J.M., Potts R.O. Stratum corneum lipid phase transitions and water barrier properties. Biochemistry. 26:1987;2382-2388.
19. Goodman M., Barry B.W. Lipid-protein-partitioning (LPP) theory of skin enhancer activity: finite dose technique. Int. J. Pharm. 57:1989;29-40.
20. Jordan V.C., Murphy C.S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev. 11:1990;49-81.
21. Jordan V.C., Parker C.J., Marrow M. Update: breast cancer treatment and prevention with antiestrogens in the 1990s. Endocr. Rev. 1:1993;82-85.
22. Knutson K., Potts R.O., Guzek D.B., Golden G.M., Lambert W.J., McKie J.M., Higuchi W.I. Macro and molecular physical-chemical consideration in understanding drug transport in the stratum corneum. J. Control. Release. 2:1985;67-87.
23. Lotte C., Rougier A., Wilson D.R., Maibach H.I. In vivo relationship between transepidermal water loss and percutaneous penetration of some organic compounds in man: effect of anatomic site. Arch. Dermatol. Res. 279:1987;351-356.
24. Maibach, H.I., Bronaugh, R., Guy, R., Turr, E., Wilson, D., Jacques, S., Chaing, D., 1984. Noninvasive techniques for determining skin function. In: Drill, V.A., Lazar, P. (Eds.), Cutaneous Toxicity. Raven Press, New York, pp. 63-97.
25. Megrab N.A., Williams A.C., Barry B.W. Oestradiol permeation across human skin, silastic and snake skin membranes: the effects of ethanol/water co-solvent system. Int. J. Pharm. 116:1995;101-112.
26. Naik A., Petchtold L.A.R.M., Potts R.O., Guy R.H. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J. Control. Release. 37:1995;299-306.
27. Nayfield S.G., Karp J.E., Ford L.G., Andrew D., Kramer B.S. Potential role of tamoxifen in prevention of breast cancer. J. Natl. Cancer Inst. 83:1991;1450-1459.
28. Ongpipattanakul B., Burnette R.R., Potts R.O., Francoeur M.L. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8:1991;350-354.
29. Potts R.O., Francoeur M.L. Lipid biophysics of water loss through the skin. Proc. Natl. Acad. Sci. USA. 87:1990;3871-3873.
30. Potts R.O., Golden G.M., Francoeur M.L., Mak V.H.W., Guy R.H. Mechanism and enhancement of solute transport across the stratum corneum. J. Control. Release. 15:1991;249-260.
31. Prausnitz M.R., Bose V.G., Langer R., Weaver J.C. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA. 90:1993;10504-10508.
32. Roberts M.S., Anderson R.A., Swarbrick J., Moore D.E. The percutaneous absorption of phenolic compounds: the mechanism of diffusion across the stratum corneum. J. Pharm. Pharmcol. 30:1978;486-490.
33. Rougier, A., Lotte, C., Maibach, H.I., 1989. In vivo relationship between percutaneous absorption and transepidermal water loss. In: Bronaugh, R.L., Maibach, H.I. (Eds), Percutaneous Absorption. Marcel Dekker, New York, pp. 175-190.
34. Scheuplein, R.J., 1978. Skin as barrier. In: Jarret, A. (Ed.), The physiology and pathophysiology of skin. Academic press, New York, pp. 1693-1730.
35. Scheuplein R.J., Blank I.H. Permeability of the skin. Physiol. Rev. 57:1971;702-747.
36. Seki T., Kawaguchi T., Sugibayashi K., Juni K., Morimoto Y. Percutaneous absorption of azidothymidine in rats. Int. J. Pharm. 57:1989;73-75.
37. Singh J., Bhatia K.S. Topical iontophoretic drug delivery: pathways, principles, factors and skin irritation. Med. Res. Rev. 16:1996;285-296.
38. Singh S., Singh J. Transdermal delivery of drugs by phonophoresis: a review. Drug Des. Deliv. 5:1990;259-265.
39. Smith, E.W., Maibach, H.I., 1995. Percutaneous penetration enhancers: the fundamental. In: Smith, E.W., Maibach, H.I. (Eds.), Percutaneous Penetration Enhancers. CRC Press, Boca Raton, pp 1-4.
40. Smith S.W., Anderson B.D. Human skin permeability enhancement by lauric acid under equilibrium aqueous conditions. J. Pharm. Sci. 84:1995;551-556.
41. Turunen T.M., Buyuktimkin S., Buyuktimkin N., Urtti A., Paronen P., Rytting J.H. Enhanced delivery of 5-fluorouracil through shed snake skin by two new transdermal penetration enhancers. Int. J. Pharm. 92:1993;89-95.
42. USP DI, 1997. Dug information for the health care professional, US Pharmacopeial Convention, Rockville, MD, pp. 1496-1502.
43. Van Duzee B.F. Thermal analysis of human stratum corneum. J. Invest. Dermatol. 65:1971;404-408.
44. Wang L.Y., Ma J.K., Pan W.F., Toledo-Velasquez D., Malanga C.J., Rojanasakul Y. Alveolar permeability enhancement by oleic acid and related fatty acids: evidence for a calcium-dependent mechanism. Pharm. Res. 11:1994;513-517.
45. Wertz P.M., Downing D.T. Glycolipids in mammalian epidermis: structure and function in the water barrier. Science. 217:1982;1261-1262.
46. Wester R.C., Maibach H.I. Percutaneous absorption of drugs. Clin. Pharmacokinet. 23:1992;235-266.
47. Williams, A.C., Barry, B.W., 1992. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9, 305-353.
48. Wilson, D.R., Maibach, H.I., 1982. A review of transepidermal water loss: physical aspects and measurements as related to infants and adults. In: Maibach, H.I., Bouititis, E.K. (Eds.), Neonatal Skin. Marcel Dekker, New York, pp. 83-100.
49. Worman H.J., Brasitus T.A., Dudeja P.K., Fozzard H.A., Field M. Relationship between lipid fluidity and water permeability of bovine tracheal epithelial cell apical membranes. Biochemistry. 25:1986;1549-1555.
50. Yamane M.A., William A.C., Barry B.W. Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int. J. Pharm. 116:1995;237-251.
51. Yu D., Sanders L.M., Davidson G.W., Marvin M.J., Ling T. Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys. Pharm. Res. 5:1988;457-462.